IM Cannabis (IMCC) EBITDA (2020 - 2026)

IM Cannabis' EBITDA history runs 7 years deep, the most recent figure standing at $859.73 for Q1 2026.

• In Q1 2026, EBITDA rose 98.65% year-over-year to $859.73; the TTM figure through Mar 2026 stood at -$3.8 million (down 168.95% YoY), while the FY2025 annual figure was -$8.3 million, down 141214.31% from the prior year.
• EBITDA was $859.73 for Q1 2026 at IM Cannabis, up from -$5.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $97.7 million in Q3 2022 to a low of -$25.0 million in Q4 2022.
• Historically, EBITDA has averaged $4.3 million across 5 years, with a median of $3673.5 in 2024.
• Biggest YoY gain for EBITDA was 2694.96% in 2022; the steepest drop was 337775.98% in 2022.
• A 5-year view of EBITDA shows it stood at -$25.0 million in 2022, then jumped by 112.3% to $3.1 million in 2023, then soared by 119.58% to $6.7 million in 2024, then tumbled by 181.87% to -$5.5 million in 2025, then jumped by 100.02% to $859.73 in 2026.
• The last three EBITDA figures came in at $859.73 (Q1 2026), -$5.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.